Neviya D

Neviah D is a computational biotechnology company specializing in the prediction of drug-induced toxicity using artificial intelligence and machine learning. The company's platform integrates diverse biological data, including multi-omics and clinical records, to identify safety biomarkers and predict adverse effects early in the drug development cycle. By providing high-resolution safety profiles, Neviah D helps pharmaceutical companies mitigate risks and reduce the attrition rate of drug candidates. Their technology is designed to bridge the gap between preclinical findings and human clinical outcomes, focusing on organ-specific toxicities such as liver and kidney damage. The company aims to transform drug safety from a reactive process to a proactive, data-driven discipline.